InMed Pharmaceuticals Inc. (INM) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

InMed Pharmaceuticals Inc. (INM) closed at USD 1.31 on 2026-10-14, a change of -34.5 % over the past year, with a market capitalization of USD 7.31M.

InMed Pharmaceuticals Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

InMed Pharmaceuticals Inc. key figures

Previous close

USD 1.31 (2026-10-14)

1-year change

-34.5 %

Market cap

USD 7.31M

Enterprise value

USD 5.07M

P/E ratio (trailing)

-0.47

P/E ratio (forward)

-0.21

EPS (trailing)

-2.84

EPS (forward)

-6.25

PEG ratio

n/a

Price to book

6.62

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.52

Employees

6

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for InMed Pharmaceuticals Inc. and compare it with other stocks.